ARPA-H grants up to $125M to accelerate on-demand custom RNA therapy manufacturing
ARPA-H announced a new funding initiative aimed at speeding the creation of personalized RNA medicines. The agency will provide up to $125 million in total awards.
Five research groups were selected to receive the grants. Their projects will focus on building platforms that can produce custom RNA therapeutics quickly and on demand.
The effort is intended to shorten development timelines and lower costs for gene-based treatments, supporting the broader goal of making precision medicines more accessible.
The funding reflects the federal government’s commitment to advancing advanced manufacturing technologies in the biotech sector.
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “ARPA-H awards $125M for manufacturing custom RNA therapies on demand”
read at Endpoints ↗
comments(0)
5-min edit window · permanent after that